Skip to main content
Top
Published in: European Radiology 4/2016

01-04-2016 | Hepatobiliary-Pancreas

Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC)

Authors: Heiko Hinrichs, Jan B. Hinrichs, Marcel Gutberlet, Henrike Lenzen, Hans-Juergen Raatschen, Frank Wacker, Kristina I. Ringe

Published in: European Radiology | Issue 4/2016

Login to get access

Abstract

Objectives

To assess the value of variable flip angle-based T1 liver mapping on gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC) for evaluation of global and segmental liver function, and determine a possible correlation with disease severity.

Methods

Sixty-one patients (19 female, 42 male; mean age 41 years) with PSC were included in this prospective study. T1 mapping was performed using a 3D-spoiled GRE sequence (flip angles 5°, 15°, 20°, 30°) before, 16 (HP1) and 132 min (HP2) after contrast injection. T1 values were measured and compared (Wilcoxon-Test) by placing ROIs in each liver segment. The mean reduction of T1 relaxation time at HP1 and HP2 was calculated and correlated with liver function tests (LFTs), MELD, Mayo Risk and Amsterdam Scores (Spearman correlation).

Results

Significant changes of T1 relaxation times between non-enhanced and gadoxetate disodium-enhanced MRI at HP1 and HP2 could be observed in all liver segments (p < 0.0001). A significant correlation of T1 reduction could be observed with LFTs, MELD and Mayo Risk Score (p < 0.05).

Conclusions

T1 mapping of the liver using a variable flip angle-based sequence is a feasible technique to evaluate liver function on a global level, and may be extrapolated on a segmental level in patients with PSC.

Key Points

T1 mapping enables evaluation of global liver function in PSC.
T1 relaxation time reduction correlates with the MELD and MayoRisk Score.
Extrapolated, T1 mapping may allow for segmental evaluation of liver function.
Literature
1.
go back to reference Porayko MK, LaRusso NF, Wiesner RH (1991) Primary sclerosing cholangitis: a progressive disease? Semin Liver Dis 11:18–25CrossRefPubMed Porayko MK, LaRusso NF, Wiesner RH (1991) Primary sclerosing cholangitis: a progressive disease? Semin Liver Dis 11:18–25CrossRefPubMed
2.
go back to reference Bjornsson E, Angulo P (2007) Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis. Am J Gastroenterol 102:1677–1682CrossRefPubMed Bjornsson E, Angulo P (2007) Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis. Am J Gastroenterol 102:1677–1682CrossRefPubMed
3.
go back to reference European Association for the Study of the Liver (2009) EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51:237–267CrossRef European Association for the Study of the Liver (2009) EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51:237–267CrossRef
4.
go back to reference Strassburg CP, Manns MP (2011) Treatment of autoimmune liver diseases. Autoimmune hepatitis and primary sclerosing cholangitis. Internist (Berl) 52:1394–1406CrossRef Strassburg CP, Manns MP (2011) Treatment of autoimmune liver diseases. Autoimmune hepatitis and primary sclerosing cholangitis. Internist (Berl) 52:1394–1406CrossRef
5.
go back to reference Weismuller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP (2008) The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 48:S38–57CrossRefPubMed Weismuller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP (2008) The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 48:S38–57CrossRefPubMed
6.
go back to reference Husarik DB, Gupta RT, Ringe KI, Boll DT, Merkle EM (2011) Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Acad Radiol 18:1549–1554CrossRefPubMed Husarik DB, Gupta RT, Ringe KI, Boll DT, Merkle EM (2011) Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Acad Radiol 18:1549–1554CrossRefPubMed
7.
go back to reference van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290:153–157PubMed van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290:153–157PubMed
8.
go back to reference Takao H, Akai H, Tajima T et al (2011) MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 77:325–329CrossRefPubMed Takao H, Akai H, Tajima T et al (2011) MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 77:325–329CrossRefPubMed
9.
go back to reference Bae KE, Kim SY, Lee SS et al (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30:617–622CrossRefPubMed Bae KE, Kim SY, Lee SS et al (2012) Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 30:617–622CrossRefPubMed
10.
go back to reference Chernyak V, Kim J, Rozenblit AM, Mazzoriol F, Ricci Z (2011) Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors. J Magn Reson Imaging 34:301–309CrossRefPubMed Chernyak V, Kim J, Rozenblit AM, Mazzoriol F, Ricci Z (2011) Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors. J Magn Reson Imaging 34:301–309CrossRefPubMed
11.
go back to reference Katsube T, Okada M, Kumano S et al (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol 46:277–283CrossRefPubMed Katsube T, Okada M, Kumano S et al (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol 46:277–283CrossRefPubMed
12.
go back to reference Nilsson H, Blomqvist L, Douglas L et al (2014) Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis. J Magn Reson Imaging 39:879–886CrossRefPubMed Nilsson H, Blomqvist L, Douglas L et al (2014) Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis. J Magn Reson Imaging 39:879–886CrossRefPubMed
13.
go back to reference Ringe KI, Hinrichs J, Merkle EM, Weismueller TJ, Wacker F, Meyer BC (2014) Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion. J Magn Reson Imaging 40:106–112CrossRefPubMed Ringe KI, Hinrichs J, Merkle EM, Weismueller TJ, Wacker F, Meyer BC (2014) Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion. J Magn Reson Imaging 40:106–112CrossRefPubMed
14.
go back to reference Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470CrossRefPubMed
15.
go back to reference Kim WR, Therneau TM, Wiesner RH et al (2000) A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75:688–694CrossRefPubMed Kim WR, Therneau TM, Wiesner RH et al (2000) A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75:688–694CrossRefPubMed
16.
go back to reference Majoie CB, Reeders JW, Sanders JB, Huibregtse K, Jansen PL (1991) Primary sclerosing cholangitis: a modified classification of cholangiographic findings. AJR Am J Roentgenol 157:495–497CrossRefPubMed Majoie CB, Reeders JW, Sanders JB, Huibregtse K, Jansen PL (1991) Primary sclerosing cholangitis: a modified classification of cholangiographic findings. AJR Am J Roentgenol 157:495–497CrossRefPubMed
17.
go back to reference Ponsioen CY, Vrouenraets SM, Prawirodirdjo W et al (2002) Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 51:562–566CrossRefPubMedPubMedCentral Ponsioen CY, Vrouenraets SM, Prawirodirdjo W et al (2002) Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 51:562–566CrossRefPubMedPubMedCentral
18.
go back to reference Klein S, Staring M, Murphy K, Viergever MA, Pluim JP (2010) elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29:196–205CrossRefPubMed Klein S, Staring M, Murphy K, Viergever MA, Pluim JP (2010) elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29:196–205CrossRefPubMed
19.
go back to reference Chang LC, Koay CG, Basser PJ, Pierpaoli C (2008) Linear least-squares method for unbiased estimation of T1 from SPGR signals. Magn Reson Med 60:496–501 Chang LC, Koay CG, Basser PJ, Pierpaoli C (2008) Linear least-squares method for unbiased estimation of T1 from SPGR signals. Magn Reson Med 60:496–501
20.
go back to reference Belghiti J, Clavien PA, Gadzijev E et al (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2:333–339 Belghiti J, Clavien PA, Gadzijev E et al (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2:333–339
21.
go back to reference Haimerl M, Verloh N, Zeman F et al (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One 8, e85658CrossRefPubMedPubMedCentral Haimerl M, Verloh N, Zeman F et al (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One 8, e85658CrossRefPubMedPubMedCentral
22.
go back to reference Yoneyama T, Fukukura Y, Kamimura K et al (2014) Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function. Eur Radiol 24:857–865CrossRefPubMed Yoneyama T, Fukukura Y, Kamimura K et al (2014) Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function. Eur Radiol 24:857–865CrossRefPubMed
23.
go back to reference Matsumata T, Kanematsu T, Yoshida Y, Furuta T, Yanaga K, Sugimachi K (1987) The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg 11:678–681CrossRefPubMed Matsumata T, Kanematsu T, Yoshida Y, Furuta T, Yanaga K, Sugimachi K (1987) The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg 11:678–681CrossRefPubMed
24.
go back to reference Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259CrossRefPubMed Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259CrossRefPubMed
25.
go back to reference Cheng HL, Stikov N, Ghugre NR, Wright GA (2012) Practical medical applications of quantitative MR relaxometry. J Magn Reson Imaging 36:805–824CrossRefPubMed Cheng HL, Stikov N, Ghugre NR, Wright GA (2012) Practical medical applications of quantitative MR relaxometry. J Magn Reson Imaging 36:805–824CrossRefPubMed
26.
go back to reference Schabel MC, Morrell GR (2009) Uncertainty in T(1) mapping using the variable flip angle method with two flip angles. Phys Med Biol 54:N1–8CrossRefPubMed Schabel MC, Morrell GR (2009) Uncertainty in T(1) mapping using the variable flip angle method with two flip angles. Phys Med Biol 54:N1–8CrossRefPubMed
27.
go back to reference Bjornsson E, Olsson R, Bergquist A et al (2008) The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 134:975–980CrossRefPubMed Bjornsson E, Olsson R, Bergquist A et al (2008) The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 134:975–980CrossRefPubMed
Metadata
Title
Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC)
Authors
Heiko Hinrichs
Jan B. Hinrichs
Marcel Gutberlet
Henrike Lenzen
Hans-Juergen Raatschen
Frank Wacker
Kristina I. Ringe
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 4/2016
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3913-y

Other articles of this Issue 4/2016

European Radiology 4/2016 Go to the issue